2024 Scrip Asia 100
Latest Updates And Considerations In Asia Pacific
Korea
Korean pharma companies are increasing collaboration with one another to overcome limited resources, capital and investment opportunities, while simultaneously strategizing for globalization.
Collaborate Rather Than Compete: Korea’s Push Toward A Biopharma Powerhouse
Korean biopharma companies and the government are making diverse efforts to collaborate and seek growth to overcome limited resources and capital, as well as a tough investment environment.
KHIDI Spearheads Support For Korea Biopharma Globalization
Korea Health Industry Development Institute President Soon-Do Cha talks to Scrip how the government agency’s support strategy to the domestic biopharma industry may be changing in line with the industry’s increased globalization move and how he views the country’s policy stance should improve going forward to meet its goal of becoming a strong biohealth nation.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.